groupH was selected to present on the topic of Looking for and Quantifying Value in Rare Diseases at an EphMRA meeting in Basel on 6th November, 2018.
Rare diseases present a number of challenges for manufacturers, which are absent in more prevalent conditions. So which approach should you take when trying to determine value?
In his presentation Erik Holzinger addresses this question and highlights some of the issues involved.
Click here to view this presentation.